3-(4-Piperidinyl)-6,7,8,9-tetrahydro-5H-1,2,4-triazolo[4,3-a]azepine Dihydrochloride is a heterocyclic compound featuring a fused triazoloazepine core with a piperidinyl substituent. This dihydrochloride salt form enhances solubility and stability, making it suitable for pharmaceutical research and development. The compound's rigid bicyclic structure and nitrogen-rich framework contribute to its potential as a versatile intermediate in medicinal chemistry, particularly for targeting central nervous system (CNS) disorders. Its high purity and well-defined chemical properties ensure reproducibility in synthetic applications. The hydrochloride salt form also facilitates handling and storage under standard laboratory conditions. This compound is primarily utilized in preclinical studies for its potential pharmacological activity.